Prenetics Global Limited, an investment holding company, operates as a diagnostics and genetic testing company. Its products include CircleDNA, a consumer genetic testing product; and Circle HealthPod, a rapid detection health monitoring system that allows users to take COVID-19 tests at point-of-care or at home utilizing the nucleic acid amplification test. The company's products also comprise ColoClear, a non-invasive FIT-DNA colorectal cancer screening test; Circle SnapShot, an off-the-shelf at-home blood test; Circle Medical, a diagnostic …
Over the last 12 months, insiders at Prenetics Global Limited have bought $0 and sold $0 worth of Prenetics Global Limited stock.
On average, over the past 5 years, insiders at Prenetics Global Limited have bought $0 and sold $0 worth of stock each year.
There was no buying activity among insiders over the last 12 months.
The last purchase of 2,000 shares for transaction amount of $138,294 was made by ZWIENER DAVID K (director) on 2011‑06‑16.
2015-12-21 | Sale | EVP & COO, PartnerRe Ltd | 710 0.1805% | $139.11 | $98,770 | +0.74% | ||
2015-09-17 | Sale | director | 5,282 1.3362% | $138.46 | $731,338 | +0.81% | ||
2015-09-16 | Sale | director | 15,613 3.9498% | $138.46 | $2.16M | +0.59% | ||
2015-02-05 | Sale | President & CEO, PartnerRe NA | 2,874 0.6357% | $121.06 | $347,933 | +13.82% | ||
2014-11-28 | Sale | CEO, PartnerRe Global | 500 0.107% | $117.15 | $58,575 | +12.45% | ||
2014-10-31 | Sale | CEO, PartnerRe Global | 2,000 0.4237% | $115.96 | $231,920 | +11.72% | ||
2014-10-23 | Sale | CEO, PartnerRe Global | 500 0.1051% | $115.00 | $57,500 | +13.92% | ||
2014-09-02 | Sale | CEO, PartnerRe Global | 500 0.1032% | $113.00 | $56,500 | +3.18% | ||
2014-08-25 | Sale | CEO, PartnerRe Global | 500 0.1014% | $111.00 | $55,500 | +4.72% | ||
2014-08-25 | Sale | director | 5,549 1.1177% | $110.25 | $611,777 | +4.72% | ||
2014-08-21 | Sale | director | 1,719 0.3463% | $110.26 | $189,545 | +5.19% | ||
2014-08-20 | Sale | director | 2,441 0.4808% | $107.81 | $263,164 | +6.17% | ||
2014-06-27 | Sale | President & CEO, PartnerRe NA | 6,061 1.2% | $108.37 | $656,825 | +5.21% | ||
2014-06-06 | Sale | CEO, PartnerRe Global | 150 0.0299% | $109.12 | $16,368 | +4.03% | ||
2014-06-05 | Sale | CEO, PartnerRe Global | 500 0.0995% | $108.90 | $54,450 | +4.15% | ||
2014-06-05 | Sale | Chief Accounting Officer | 1,894 0.3745% | $108.21 | $204,955 | +4.15% | ||
2014-05-23 | Sale | CEO, PartnerRe Global | 500 0.0986% | $107.90 | $53,950 | +5.93% | ||
2014-05-02 | Sale | CEO, PartnerRe Global | 500 0.0977% | $106.90 | $53,450 | +5.83% | ||
2014-04-29 | Sale | CEO, PartnerRe Global | 200 0.039% | $106.63 | $21,326 | +6.19% | ||
2013-12-31 | Sale | CEO, PartnerRe Global | 300 0.058% | $105.90 | $31,770 | +2.61% |
THIELE PATRICK A | Former Chief Executive Officer | 213446 1.7471% | $5.80 | 10 | 6 | +5.45% |
ROLLWAGEN JOHN A | director | 13116 0.1074% | $5.80 | 1 | 26 | +7.29% |
PABST MARK | EVP | 12069 0.0988% | $5.80 | 5 | 1 | +1.81% |
ZWIENER DAVID K | director | 5587 0.0457% | $5.80 | 2 | 0 | <0.0001% |